Search Results - "Fryksmark, U"

The incidence of adverse events in Swedish hospitals: a retrospective medical record review study by Soop, Michael, Fryksmark, Ulla, Köster, Max, Haglund, Bengt

“…Objectives To estimate the incidence, nature and consequences of adverse events and preventable adverse events in Swedish hospitals. Design A three-stage…”
Get full text

A new administration form of the nasal decongestant oxymetazoline: a study on the change of ostial patency in healthy individuals by Jannert, M, Fryksmark, U, Ackerhans, M, Nilson, K

“…A new administration form of the nasal decongestant oxymetazoline and the effect on patency of the maxillary ostium was investigated in five healthy…”
Get more information

Myeloperoxidase activity in smokers; an additional factor in the development of pulmonary emphysema by Fryksmark, U

Get more information

Secretory leukocyte protease inhibitor in normal, allergic and virus induced nasal secretions by Fryksmark, U, Jannert, M, Ohlsson, K, Tegner, H, Wihl, J A

“…Secretory leukocyte protease inhibitor (SLPI) and alpha-1-proteinase inhibitor (alpha-1-PI), both inhibitors of granulocyte elastase, were studied in nasal…”
Get more information

Kinetics of the inhibition of leukocyte elastase by the bronchial inhibitor by Gauthier, F, Fryksmark, U, Ohlsson, K, Bieth, J G

“…The rate constant for the association between human leukocyte elastase (EC 3.4.21.11) and human bronchial inhibitor has been determined by competition…”
Get more information

Antileukoprotease in patients with maxillary sinusitis by Fryksmark, U, Jannert, M, Ohlsson, K, Tegner, H

“…Antileukoprotease, an inhibitor of leukocyte elastase, was studied in paired sera from 12 patients with maxillary sinusitis. The serum concentration of…”
Get more information

Localization of antileukoprotease in the parotid and the submandibular salivary glands by Ohlsson, M, Fryksmark, U, Polling, A, Tegner, H, Ohlsson, K

“…Antileukoprotease is the dominating inhibitor of granulocyte elastase and cathepsin G in normal human mixed and parotid saliva. The distribution of…”
Get more information

The mucosal defence capacity against proteolytic leukocyte enzymes by Fryksmark, U, Ohlsson, K, Tegner, H

“…Antileukoprotease is an important inhibitor of leukocyte elastase and seems to be the primary defence factor against elastase in the respiratory tract. The…”
Get more information

Interaction of granulocyte proteases with inhibitors in pulmonary diseases by Ohlsson, K, Fryksmark, U, Ohlsson, M, Tegner, H

“…The elastase-antielastase hypothesis of lung tissue destruction has focused our interest on the two main inhibitors of granulocyte elastase in the lung, alpha…”
Get more information

Studies on the role of antileukoprotease in respiratory tract diseases by Fryksmark, U, Prellner, T, Tegner, H, Ohlsson, K

“…Antileukoprotease, an inhibitor of granulocyte elastase, was studied in paired sera from 19 patients with pneumonia and from 9 patients with…”
Get more information

Adverse events in hospitals are common. The majority can be avoided according to a study of medical records by Soop, Michael, Fryksmark, Ulla, Köster, Max, Haglund, Bengt

Get more information

Is there a relationship between the degree of nasal obstruction and snoring? by Jessen, M, Fryksmark, U

“…The possible connection between snoring and nasal obstruction was studied in three groups of adult patients. In group 1, comprising 112 unselected patients,…”
Get more information

Localisation of secretory leucocyte proteinase inhibitor mRNA in nasal mucosa by Westin, U, Fryksmark, U, Polling, A, Ohlsson, K

“…Human secretory leucocyte proteinase inhibitor (SLPI) is a low-molecular weight, acid-stable inhibitor of polymorph-nuclear granulocyte elastase and cathepsin…”
Get more information

The effect of cigarette smoke condensate on alpha 1-antitrypsin, antileukoprotease and granulocyte elastase by Ohlsson, K, Fryksmark, U, Tegner, H

“…Unfractionated cigarette smoke condensate was found to affect alpha 1-antitrypsin and antileukoprotease, which are the dominating enzyme inhibitors in the…”
Get more information

Distribution of antileukoprotease in upper respiratory mucosa by Fryksmark, U, Ohlsson, K, Polling, A, Tegner, H

“…Human respiratory tract secretions contain enzyme inhibitors derived from plasma and a low molecular weight, acid-stable protease inhibitor, antileukoprotease…”
Get more information

The mucosal defence capacity against proteolytic leukocyte enzymes by Tegner, H, Fryksmark, U, Ohlsson, K

“…Proteolytic enzymes are released from granulocytes in connection with normal turnover and phagocytosis. Interest has been focused on granulocyte elastase as it…”
Get more information

A radioimmunoassay for measurement and characterization of human antileukoprotease in serum by Fryksmark, U, Ohlsson, K, Rosengren, M, Tegner, H

“…This report describes a radioimmunological method for the measurement of the protease inhibitor antileukoprotease in nanogram quantities. Antileukoprotease,…”
Get more information

Studies on the interaction between leukocyte elastase, antileukoproteinase and the plasma proteinase inhibitors alpha 1-proteinase inhibitor and alpha 2-macroglobulin by Fryksmark, U, Ohlsson, K, Rosengren, M, Tegner, H

“…The dominating inhibitor of leukocyte elastase in human respiratory tract secretions is a low molecular mass inhibitor, designated antileukoproteinase. An…”
Get more information